Merck to Pay $830 Million to Settle Vioxx Securities Claims

Updated on
  • Company paid more than $8.5 billion over drug pulled in 2004
  • Vioxx pulled over increased risk of heart attacks, strokes

More than 11 years after pulling its Vioxx painkiller from the market, Merck & Co. agreed to pay another $830 million to settle litigation, raising its total payouts in lawsuits and government investigations to more than $8.5 billion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.